Report

Regulated Delivery of Therapeutic Proteins After in Vivo Somatic Cell Gene Transfer

Science  01 Jan 1999:
Vol. 283, Issue 5398, pp. 88-91
DOI: 10.1126/science.283.5398.88

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Stable delivery of a therapeutic protein under pharmacologic control was achieved through in vivo somatic gene transfer. This system was based on the expression of two chimeric, human-derived proteins that were reconstituted by rapamycin into a transcription factor complex. A mixture of two adeno-associated virus vectors, one expressing the transcription factor chimeras and one containing erythropoietin (Epo) under the control of a promoter responsive to the transcription factor, was injected into skeletal muscle of immune-competent mice. Administration of rapamycin resulted in 200-fold induction of plasma Epo. Stable engraftment of this humanized system in immune-competent mice was achieved for 6 months with similar results for at least 3 months in a rhesus monkey.

  • * To whom correspondence should be addressed. E-mail: wilsonjm{at}mail.med.upenn.edu

View Full Text

Related Content